0001590750-21-000029 Sample Contracts

MIRAGEN THERAPEUTICS, INC. EMPLOYMENT AGREEMENT

Employment Agreement • March 26th, 2021 • Viridian Therapeutics, Inc.\DE • Services-medical laboratories • New York

• Contract Type
  Employment Agreement
• Filed
  March 26th, 2021
• Company
  Viridian Therapeutics, Inc.\DE
• Industry
  Services-medical laboratories
• Jurisdiction
  New York

This EMPLOYMENT AGREEMENT (the “Agreement”), dated as of January 18, 2021 (the “Effective Date”), is by and between miRagen Therapeutics, Inc., a Delaware corporation (the “Company”), and Barrett Katz, MD (residing at 800 Strohson Road, Cutchogue, New York, 11935) (“Executive”).

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE REDACTED PORTIONS ARE MARKED AS [***]. TECHNOLOGY LICENSE AGREEMENT

Technology License Agreement • March 26th, 2021 • Viridian Therapeutics, Inc.\DE • Services-medical laboratories • New York

• Contract Type
  Technology License Agreement
• Filed
  March 26th, 2021
• Company
  Viridian Therapeutics, Inc.\DE
• Industry
  Services-medical laboratories
• Jurisdiction
  New York

This TECHNOLOGY LICENSE AGREEMENT (this “Agreement”), effective as of December 16, 2020 (the “Effective Date”), is made by and between Miragen Therapeutics, Inc., a Delaware corporation (“Company”), having a principal place of business at 6200 Lookout Road, Boulder, Colorado 80301, and Xencor, Inc., a Delaware corporation (“Xencor”), having a principal place of business at 111 West Lemon Avenue, Monrovia, California 91016. Company and Xencor may each be referred to herein, individually, as a “Party” or, collectively, as the “Parties.”

SUBSCRIPTION AGREEMENT

Subscription Agreement • March 26th, 2021 • Viridian Therapeutics, Inc.\DE • Services-medical laboratories • Delaware

• Contract Type
  Subscription Agreement
• Filed
  March 26th, 2021
• Company
  Viridian Therapeutics, Inc.\DE
• Industry
  Services-medical laboratories
• Jurisdiction
  Delaware

This Subscription Agreement (this “Agreement”), dated December 16, 2020, is by and between Miragen Therapeutics, Inc., a Delaware corporation (the “Company”) and Xencor, Inc., a Delaware corporation (“Subscriber”).

SEPARATION AND RELEASE AGREEMENT

Separation and Release Agreement • March 26th, 2021 • Viridian Therapeutics, Inc.\DE • Services-medical laboratories • Colorado

• Contract Type
  Separation and Release Agreement
• Filed
  March 26th, 2021
• Company
  Viridian Therapeutics, Inc.\DE
• Industry
  Services-medical laboratories
• Jurisdiction
  Colorado

This SEPARATION AND RELEASE AGREEMENT (this “Agreement”) is entered into between the undersigned individual (“Executive”) and Miragen Therapeutics, Inc., a Delaware corporation (the “Company”) and is dated as of January 1, 2021. Reference is made to that certain Employment Agreement, dated February 20, 2020, by and between Executive and the Company (the “Employment Agreement”) and that certain Bonus Letter Agreement, dated September 27, 2020, by and between Executive and the Company (the “Bonus Agreement”).